Literature DB >> 17220420

Daptomycin susceptibility of unusual gram-positive bacteria: comparison of results obtained by the Etest and the broth microdilution method.

Yu-Tsung Huang1, Chun-Hsing Liao, Lee-Jeng Teng, Po-Ren Hsueh.   

Abstract

MICs of daptomycin, linezolid, and vancomycin against 212 isolates, including Listeria monocytogenes and Pediococcus, Leuconostoc, Rhodococcus, and Nocardia spp., were determined by the broth microdilution method; daptomycin MICs were also determined by the Etest. Except with those for Leuconostoc spp., daptomycin Etest MICs showed >90% agreement with MICs obtained by the broth microdilution method.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17220420      PMCID： PMC1855499          DOI： 10.1128/AAC.01352-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

1.  Daptomycin for line-related Leuconostoc bacteraemia.

Authors:  Y Golan; D D Poutsiaka; S Tozzi; S Hadley; D R Snydman
Journal:  J Antimicrob Chemother       Date:  2001-03       Impact factor: 5.790

2.  In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers.

Authors:  A L Barry; P C Fuchs; S D Brown
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests.

Authors:  P C Fuchs; A L Barry; S D Brown
Journal:  Diagn Microbiol Infect Dis       Date:  2000-09       Impact factor: 2.803

4.  In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections.

Authors:  Ellie J C Goldstein; Diane M Citron; Yumi A Warren; Kerin L Tyrrell; C Vreni Merriam; Helen T Fernandez
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

5.  Invasive listeriosis in Denmark 1994-2003: a review of 299 cases with special emphasis on risk factors for mortality.

Authors:  P Gerner-Smidt; S Ethelberg; P Schiellerup; J J Christensen; J Engberg; V Fussing; A Jensen; C Jensen; A M Petersen; B G Bruun
Journal:  Clin Microbiol Infect       Date:  2005-08       Impact factor: 8.067

6.  Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest.

Authors:  Y Glupczynski; C Berhin; M Janssens; G Wauters
Journal:  Clin Microbiol Infect       Date:  2006-09       Impact factor: 8.067

7.  In vitro activities of linezolid against multiple Nocardia species.

Authors:  B A Brown-Elliott; S C Ward; C J Crist; L B Mann; R W Wilson; R J Wallace
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

8.  In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis.

Authors:  L Vera-Cabrera; A Gómez-Flores; W G Escalante-Fuentes; O Welsh
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

Review 9.  Rhodococcus equi infections in immunocompetent hosts: case report and review.

Authors:  I Kedlaya; M B Ing; S S Wong
Journal:  Clin Infect Dis       Date:  2001-01-24       Impact factor: 9.079

Review 10.  Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy.

Authors:  Barbara A Brown-Elliott; June M Brown; Patricia S Conville; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132
View more
  11 in total

1.  Pediococcus acidilactici endocarditis successfully treated with daptomycin.

Authors:  Peter C Iwen; Cezarina Mindru; Andre C Kalil; Diana F Florescu
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

2.  Comparison of Etest, disk diffusion, and broth macrodilution for in vitro susceptibility testing of Rhodococcus equi.

Authors:  Londa J Berghaus; Steeve Giguère; Kristen Guldbech; Eleanor Warner; Ukachi Ugorji; Roy D Berghaus
Journal:  J Clin Microbiol       Date:  2014-11-05       Impact factor: 5.948

3.  Increased temperature enhances the antimicrobial effects of daptomycin, vancomycin, tigecycline, fosfomycin, and cefamandole on staphylococcal biofilms.

Authors:  Stefan Hajdu; Johannes Holinka; Sonja Reichmann; Alexander M Hirschl; Wolfgang Graninger; Elisabeth Presterl
Journal:  Antimicrob Agents Chemother       Date:  2010-08-02       Impact factor: 5.191

4.  Multicenter study in Taiwan of the in vitro activities of nemonoxacin, tigecycline, doripenem, and other antimicrobial agents against clinical isolates of various Nocardia species.

Authors:  Chih-Cheng Lai; Wei-Lun Liu; Wen-Chien Ko; Yen-Hsu Chen; Hon-Ren Tan; Yu-Tsung Huang; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

5.  Leuconostoc species endocarditis in an intravenous drug user.

Authors:  Damian Valencia; Victor Valencia; Adam Fershko
Journal:  J Cardiol Cases       Date:  2018-05-09

Review 6.  A current perspective on daptomycin for the clinical microbiologist.

Authors:  Romney M Humphries; Simon Pollett; George Sakoulas
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

7.  Activity of daptomycin against Listeria monocytogenes isolates from cerebrospinal fluid.

Authors:  Lodewijk Spanjaard; Christina M J E Vandenbroucke-Grauls
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

8.  Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms.

Authors:  Elisabeth Presterl; Stefan Hajdu; Andrea M Lassnigg; Alexander M Hirschl; Johannes Holinka; Wolfgang Graninger
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

9.  The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion.

Authors:  Christoph M Ernst; Petra Staubitz; Nagendra N Mishra; Soo-Jin Yang; Gabriele Hornig; Hubert Kalbacher; Arnold S Bayer; Dirk Kraus; Andreas Peschel
Journal:  PLoS Pathog       Date:  2009-11-13       Impact factor: 6.823

10.  Left thigh phlegmon caused by Nocardia farcinica identified by 16S rRNA sequencing in a patient with leprosy: a case report.

Authors:  Pasquale De Nardo; Maria Letizia Giancola; Salvatore Noto; Elisa Gentilotti; Piero Ghirga; Chiara Tommasi; Rita Bellagamba; Maria Grazia Paglia; Emanuele Nicastri; Andrea Antinori; Angela Corpolongo
Journal:  BMC Infect Dis       Date:  2013-04-04       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.